PMID- 10811820 OWN - NLM STAT- MEDLINE DCOM- 20000615 LR - 20191210 IS - 0021-9525 (Print) IS - 1540-8140 (Electronic) IS - 0021-9525 (Linking) VI - 149 IP - 4 DP - 2000 May 15 TI - Intracellular Ca(2+) and Ca(2+)/calmodulin-dependent kinase II mediate acute potentiation of neurotransmitter release by neurotrophin-3. PG - 783-92 AB - Neurotrophins have been shown to acutely modulate synaptic transmission in a variety of systems, but the underlying signaling mechanisms remain unclear. Here we provide evidence for an unusual mechanism that mediates synaptic potentiation at the neuromuscular junction (NMJ) induced by neurotrophin-3 (NT3), using Xenopus nerve-muscle co-culture. Unlike brain-derived neurotrophic factor (BDNF), which requires Ca(2+) influx for its acute effect, NT3 rapidly enhances spontaneous transmitter release at the developing NMJ even when Ca(2+) influx is completely blocked, suggesting that the NT3 effect is independent of extracellular Ca(2+). Depletion of intracellular Ca(2+) stores, or blockade of inositol 1, 4, 5-trisphosphate (IP3) or ryanodine receptors, prevents the NT3-induced synaptic potentiation. Blockade of IP3 receptors can not prevent BDNF-induced potentiation, suggesting that BDNF and NT3 use different mechanisms to potentiate transmitter release. Inhibition of Ca(2+)/calmodulin-dependent kinase II (CaMKII) completely blocks the acute effect of NT3. Furthermore, the NT3-induced potentiation requires a continuous activation of CaMKII, because application of the CaMKII inhibitor KN62 reverses the previously established NT3 effect. Thus, NT3 potentiates neurotransmitter secretion by stimulating Ca(2+) release from intracellular stores through IP3 and/or ryanodine receptors, leading to an activation of CaMKII. FAU - He, X AU - He X AD - Unit on Synapse Development and Plasticity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA. FAU - Yang, F AU - Yang F FAU - Xie, Z AU - Xie Z FAU - Lu, B AU - Lu B LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - J Cell Biol JT - The Journal of cell biology JID - 0375356 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (CAMK2N2 protein, human) RN - 0 (Calcium Channel Blockers) RN - 0 (Calcium Channels) RN - 0 (Carrier Proteins) RN - 0 (ITPR1 protein, human) RN - 0 (Inositol 1,4,5-Trisphosphate Receptors) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Neurotransmitter Agents) RN - 0 (Neurotrophin 3) RN - 0 (Receptors, Cytoplasmic and Nuclear) RN - 0 (Ryanodine Receptor Calcium Release Channel) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinase Type 2) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/pharmacology MH - Calcium/*metabolism MH - Calcium Channel Blockers/pharmacology MH - Calcium Channels/metabolism MH - Calcium-Calmodulin-Dependent Protein Kinase Type 2 MH - Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors/*metabolism MH - Carrier Proteins MH - Cells, Cultured MH - Coculture Techniques MH - Electric Conductivity MH - Enzyme Activation MH - Inositol 1,4,5-Trisphosphate Receptors MH - Intracellular Signaling Peptides and Proteins MH - Neuromuscular Junction/physiology MH - Neurotransmitter Agents/*metabolism MH - Neurotrophin 3/*pharmacology MH - Patch-Clamp Techniques MH - Presynaptic Terminals/physiology MH - Receptors, Cytoplasmic and Nuclear/metabolism MH - Ryanodine Receptor Calcium Release Channel/metabolism MH - Synaptic Transmission/*physiology MH - Xenopus PMC - PMC2174561 EDAT- 2000/05/17 09:00 MHDA- 2000/06/17 09:00 PMCR- 2000/11/15 CRDT- 2000/05/17 09:00 PHST- 2000/05/17 09:00 [pubmed] PHST- 2000/06/17 09:00 [medline] PHST- 2000/05/17 09:00 [entrez] PHST- 2000/11/15 00:00 [pmc-release] AID - 0002067 [pii] AID - 10.1083/jcb.149.4.783 [doi] PST - ppublish SO - J Cell Biol. 2000 May 15;149(4):783-92. doi: 10.1083/jcb.149.4.783.